UK Biotech Investment Rises 17% as European Coalition Tackles Funding Crisis
Jul 13, 2026
UK biotech financing jumped 17% to £552m in Q1 2026, capturing over half of European VC. Meanwhile, a new coalition of VCs managing €24 billion aims to reverse Europe's 7% share of global life sciences venture capital. Separately, CriteriaCaixa commits €300m for early-stage biotech and tech by 2030.